Company intelligence / Profile preview

Q30 Innovations

Westport, Connecticut, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Q30 Innovations has developed the Q-Collar, the first FDA-cleared device designed to help protect the brain from repetitive head impacts. The device works by exerting compressive force on the sternocleidomastoid muscles, causing a slight increase in blood volume in the skull to help reduce brain movement. The product is based on over a decade of research including 28 independent laboratory, clinical and wearability studies.[1][4]

Therapeutic areas: Neurology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

University of Maryland[1]Baylor University[1]Michigan State University[1]U.S. Army Medical Materiel Development Activity[5]Sussex IM (manufacturing partner)[4]

Beyond the preview

Go deeper on Q30 Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q30 Innovations.

Explore the full profile